1,200
Participants
Start Date
September 23, 2025
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2026
Finerenone (Kerendia, BAY948862)
Retrospective cohort analysis using the investigator or a delegate at the study site collects secondary/historic data of finerenone usage (patient demographic and clinical characteristics, diagnosis-related, treatment-related, and laboratory data) from clinic specific medical records.
Many locations, Multiple Locations
Lead Sponsor
Bayer
INDUSTRY